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Introduction 
Pheochromocytomas are rare, mostly benign tumours arising from chromaffin cells of the 
adrenal medulla or many extra-adrenal locations (where they are called paragangliomas). 
They constitute 7% (1.5–14%) of all adrenal incidentalomas [1] and are extremely rare in 
pregnant women, with a prevalence of 1 in 54,000 pregnancies [2]. The diagnosis is a 
demanding challenge because the clinical picture ranges from asymptomatic cases to life-
threatening hypertensive crises. The disease poses a serious risk to both the mother and the 
foetus, with a mortality rate of 40–50% in untreated cases [3]. Therefore, developing a 
systematic, individualised approach by a multidisciplinary team is crucial for the management 
of the disease and its consequences. 
In this paper, we describe two cases of pheochromocytoma in pregnant women and provide 
insight into possible dissimilarities in diagnosis, management, and treatment of the disease.  
 
Case no. 1 
A 29-year-old pregnant woman at nine weeks of menstrual age, with recently diagnosed 
multiple endocrine neoplasia type 2A (MEN2A) syndrome presented herself to the 
endocrinology outpatient clinic with no symptoms. Blood pressure was 130/80 mmHg with 
regular heart rate of 80 bpm. Ultrasound revealed multiple hypoechogenic thyroid nodules 
and right adrenal hypoechogenic mass (15 mm in diameter). During further diagnostics in the 
Endocrinology Department, the patient remained asymptomatic and normotensive. Urinary 
catecholamine metabolites were elevated (Tab. I). Magnetic resonance imaging (MRI) 
revealed lesions in both adrenal glands (Fig. 1A). Moreover, fine needle biopsy of thyroid 
nodules was performed, with a histological image corresponding to medullary cancer. The 
patient did not consent to any surgical procedure during pregnancy, so adrenalectomy and 
thyroidectomy were postponed until after delivery. Conservative treatment with alpha- and 
beta-blockers (doxazosin, propranolol) was started. Due to risk of preterm delivery, caesarean 
section was performed in the 33rd week of pregnancy. Preoperatively, a high risk of 
hypertensive crisis was recognised, but eventually her blood pressure of 170/100 was lowered 
and stabilised with alpha-blockers and beta-blockers. The rest of the delivery was uneventful. 
Six weeks later, the patient underwent successful laparoscopic bilateral adrenalectomy. In the 
pathology report, bilateral pheochromocytomas were confirmed. Six weeks after that, total 
thyroidectomy was performed. During follow-up, urinary catecholamine metabolites (Table 1) 
and blood pressure were normal. Recovery was satisfactory, the patient remains under regular 
surveillance in our Department due to MEN2A syndrome. 
 
Case no. 2  
A 29-year-old woman with history of MEN 2A syndrome, medullary thyroid cancer, and 
primary hyperparathyroidism. Elevated urinary catecholamine metabolites were discovered 
during a routine follow-up (Tab. I). The patient reported “paroxysmal fatigue”. On 
examination, blood pressure was 105/70 mm Hg and heart rate was regular at 68 bpm. MRI 
was performed, revealing two lesions in the right adrenal gland and one in the left adrenal 
gland (Fig. 1B and 1C). Combined results were suggestive of bilateral pheochromocytomas. 
Adrenalectomy was planned, but due to the discovery of early pregnancy (10th week), the 
procedure was postponed until the second trimester. Conservative treatment with doxazosin 
was initiated. In the 21st week of pregnancy, a right-side open adrenalectomy was performed. 
Perioperatively, doxazosin was used to prevent blood pressure spikes. The decision was made 
to keep the left adrenal gland under observation. In the pathology report, two 
pheochromocytomas were identified. The rest of the pregnancy and the delivery were 
uneventful. During follow-up, no significant rises in urinary catecholamine metabolites (Tab. 
I) or blood pressure were observed. After that, the patient stopped reporting to our 
department. 
 
Discussion 
Pheochromocytoma in pregnancy is a rare and complex condition. Sustained hypertension or 
hypertensive crises are dangerous to the mother; moreover, vasoconstriction in the 
uteroplacental circulation caused by excess catecholamines can lead to intrauterine hypoxia 
and placental abruption [4]. Despite the rarity of such a diagnosis, physicians should be aware 
of pheochromocytoma as one of the possible causes of gestational hypertension [5]. As our 
cases prove, caution should be taken when examining even the asymptomatic patients with 
germline mutations associated with this tumour. Hereditary pheochromocytoma constitutes 
around 30% of all cases [3].  
Surgery is the treatment of choice, with the laparoscopic approach being the preferred one 
nowadays [4]. The second trimester is considered to be optimal because the organogenesis of 
the foetus is already complete and the pregnant uterus does not block the view as much as it 
would in the third trimester [3]. Conservative and perioperative treatments consist of an 
alpha-blocker and an optional beta-blocker [3,4]. 
No standardised guidelines for treatment of pheochromocytoma in pregnancy have been 
established, which forces clinicians to rely on their own experience. Early diagnosis and 
appropriate treatment, with correctly timed surgery being the method of choice, are the keys 
to keeping both the mother and the foetus safe. 
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Table I. Urinary catecholamine metabolites in two cases of pregnant women before and after 
adrenalectomy 
 
Normal value 
Case no. 1 Case no. 2 
Before After Before After 
NMN [µg/24 h] 88–440 1137.6 178.1 583.2 325.1 
MN [µg/24 h] 52–341 1654.6 Undetectable 564.7 305.7 
3-MT [µg/24 h] 0–220 163.2 59.9 144.9 148.9 
NMN — normetanephrine; MN — metanephrine; 3-MT— 3-methoxytyramine  
 
Figure 1. Magnetic resonance imaging of the abdomen without gadolinium. A. Case no. 
1: A 40 × 24 mm heterogenous mass in the left adrenal gland and a 25 × 17 mm, mostly 
homogenous mass in the right adrenal gland; B. Case no. 2.: A 18 × 12 mm lesion with 
moderately high signal intensity in T2-weighted imaging in the right adrenal gland. In the left 
adrenal gland, a 17 × 11 mm mass is present, with similarly increased T2 signal. C. Case no. 
2. A 18 × 15 mm mass in the right adrenal gland 
 
